The 12 analysts offering 1 year price forecasts for 8EM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 19 analysts giving stock ratings to 8EM in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
8EM EPS for the last quarter is −0.64 CHF despite the estimation of −0.63 CHF. In the next quarter EPS is expected to reach −0.31 CHF. Track more of EDITAS MEDICINE IN financials and stay on top of what is up with the company.
In the next quarter EDITAS MEDICINE IN revenue is expected to reach 26.61 M CHF. Check out EDITAS MEDICINE IN revenue and earnings and make informed decisions.
According to analysts, 8EM price target is 4.61 CHF with a max estimate of 11.61 CHF and a min estimate of 0.89 CHF. Check if this forecast comes true in a year, meanwhile watch EDITAS MEDICINE IN stock price chart and keep track of the current situation with 8EM news and stock market news.
We've gathered opinions of 19 analysts rating 8EM stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.